{"id":965805,"date":"2026-05-21T08:10:09","date_gmt":"2026-05-21T12:10:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/"},"modified":"2026-05-21T08:10:09","modified_gmt":"2026-05-21T12:10:09","slug":"spyglass-pharma-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"SpyGlass Pharma to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ALISO VIEJO, Calif., May  21, 2026  (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences:<\/p>\n<p>\n        <strong>Stifel 2026 Virtual Ophthalmology Forum<\/strong><br \/>\n        <br \/>Date: Tuesday, May 26, 2026<br \/>Time: 2:00 p.m. ET<br \/>Format: Fireside Chat<\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference<\/strong><br \/>\n        <br \/>Date: Thursday, June 4, 2026<br \/>Time: 2:35 p.m. ET<br \/>Format: Fireside Chat<\/p>\n<p>\n        <strong>Goldman Sachs 47<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Date: Wednesday, June 10, 2026<br \/>Time: 10:40 a.m. ET<br \/>Format: Corporate Presentation<\/p>\n<p>A live webcast and subsequent replay of each presentation can be accessed via the Investor Relations section of the Company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q9wZMJiLnRe56uGFjdiXh0E4Pi6sbdq61kBydrSsAbpplypLEg0whinG_74Dc-RrKuqPFYMltLwwvmcmbrOCMBVyZw6rT4aCrAb-g6k7eR3022_vSMz4KArHvCGdp-TBpBaA1ig2wdC3i3HKyrqZTlCV1sEnVt3V9Fa3oVTVwYfJUREqL2h4PNoN3woUdN5x7atgU8okrxOXudv6s3LBLjZHQJFB-k29NMrQN0L5MUYgruLP5EB3b9svg3J8Lk_L1AIwzggNycLbbdDRsvu3n4T9jmevcvN7yTCdcNEcuCDh0IMjURfvnQF6CNiHBpYgFUYtRCegEj4w7_yVsspjp5YcMbJaJPmLsXDJ50AwcBuZIDSv5AOkAYZuJ-JQm_2hxS9vF-d-llG4W-8gf-Mt5xoG_gUabh8NaSiz7P8Et7bBlMur8m15h2f-ct-j7tAF\" rel=\"nofollow\" target=\"_blank\">www.spyglasspharma.com<\/a>.<\/p>\n<p>\n        <strong>About SpyGlass Pharma<\/strong>\n      <\/p>\n<p>SpyGlass Pharma is a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company\u2019s mission is to significantly improve the lives of patients with chronic eye conditions by developing durable drug delivery solutions that can empower patients and surgeons with confidence in long-term disease control and vision preservation.<\/p>\n<p>The SpyGlass Pharma platform, a novel, non-bioerodible drug delivery technology, is designed to be used with various well-established, approved medicines, including bimatoprost and other small molecules, providing flexibility to potentially treat a range of conditions in the front and back of the eye. <\/p>\n<p>The company was founded in 2019 by Malik Y. Kahook, M.D. and Glenn Sussman to solve the lack of ophthalmic innovations that capitalize on durable treatment options. The SpyGlass Pharma platform was originally developed in the Sue Anschutz-Rodgers Eye Center at the University of Colorado Anschutz School of Medicine.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Nami Surendranath<br \/>+1 (402) 507-6757<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=am61a5xAM8wi5U3V57T4WD7RR6KKzy7iuplDLiMfpRO8b1iHEgeGuZphs8Ff8FIPZhZAV09uLDEqZA_SnflCLhYyMZhipMn_42PCsbKKSJTIrKsEQ-sJiZpeQrkRSqxf4ibLWC4dSun2cPJQUoUvzA==\" rel=\"nofollow\" target=\"_blank\"><u>nsurendranath@dnacommunications.com<\/u><\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Ami Bavishi or Nick Colangelo<br \/>Gilmartin Group LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LsYrcCOSudxix02ZBOTnlzXnRKKthDM0iwprJkkZSaE_CIdoGtjL71Uah_5F6Zo6qu19uncjfEl9yapdAgQJ81sr7cOcXZn_n4mYUm_s3mk4CaPkPFyy_PrfitCbFEo4\" rel=\"nofollow\" target=\"_blank\"><u>investors@spyglasspharma.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzZhZmRhMmUtZmYwYS00Y2ViLThhZjItNmYyMmU0NzAzOGEyLTEyNjQwMTktMjAyNi0wNS0yMS1lbg==\/tiny\/Spyglass-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALISO VIEJO, Calif., May 21, 2026 (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026Time: 2:00 p.m. ETFormat: Fireside Chat Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026Time: 2:35 p.m. ETFormat: Fireside Chat Goldman Sachs 47 th Annual Global Healthcare Conference Date: Wednesday, June 10, 2026Time: 10:40 a.m. ETFormat: Corporate Presentation A live webcast and subsequent replay of each presentation can be accessed via the Investor Relations section of the Company website at www.spyglasspharma.com. About SpyGlass Pharma SpyGlass Pharma is a late-stage biopharmaceutical company dedicated to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SpyGlass Pharma to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-965805","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALISO VIEJO, Calif., May 21, 2026 (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026Time: 2:00 p.m. ETFormat: Fireside Chat Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026Time: 2:35 p.m. ETFormat: Fireside Chat Goldman Sachs 47 th Annual Global Healthcare Conference Date: Wednesday, June 10, 2026Time: 10:40 a.m. ETFormat: Corporate Presentation A live webcast and subsequent replay of each presentation can be accessed via the Investor Relations section of the Company website at www.spyglasspharma.com. About SpyGlass Pharma SpyGlass Pharma is a late-stage biopharmaceutical company dedicated to &hellip; Continue reading &quot;SpyGlass Pharma to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-21T12:10:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SpyGlass Pharma to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-05-21T12:10:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=\",\"datePublished\":\"2026-05-21T12:10:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SpyGlass Pharma to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"ALISO VIEJO, Calif., May 21, 2026 (GLOBE NEWSWIRE) &#8212; SpyGlass Pharma, Inc. (Nasdaq: SGP) (\u201cSpyGlass Pharma\u201d or \u201cCompany\u201d), a late-stage biopharmaceutical company, today announced that members of the executive management team will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026Time: 2:00 p.m. ETFormat: Fireside Chat Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026Time: 2:35 p.m. ETFormat: Fireside Chat Goldman Sachs 47 th Annual Global Healthcare Conference Date: Wednesday, June 10, 2026Time: 10:40 a.m. ETFormat: Corporate Presentation A live webcast and subsequent replay of each presentation can be accessed via the Investor Relations section of the Company website at www.spyglasspharma.com. About SpyGlass Pharma SpyGlass Pharma is a late-stage biopharmaceutical company dedicated to &hellip; Continue reading \"SpyGlass Pharma to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-21T12:10:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SpyGlass Pharma to Participate in Upcoming Investor Conferences","datePublished":"2026-05-21T12:10:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/"},"wordCount":291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/","name":"SpyGlass Pharma to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=","datePublished":"2026-05-21T12:10:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNDAzNyM3NjEzODE3IzIyNTI0NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyglass-pharma-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SpyGlass Pharma to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=965805"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/965805\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=965805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=965805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=965805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}